MCF7_TG2 cells showed increased invasiveness compared to MCF7_Cont cells, and IL-1β treatment further increased the invasiveness of MCF7_TG2 breast cancer cells (Fig. 3a and b). This evidence concerns the gene IL1B and breast carcinoma.